Chemoinformaics analysis of (2R,3S)-glycosmisic acid
| Molecular Weight | 372.373 | nRot | 6 |
| Heavy Atom Molecular Weight | 352.213 | nRig | 18 |
| Exact Molecular Weight | 372.121 | nRing | 3 |
| Solubility: LogS | -3.539 | nHRing | 1 |
| Solubility: LogP | 2.343 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 52.3499 |
| nHD | 3 | BPOL | 26.1401 |
| QED | 0.67 |
| Synth | 3.324 |
| Natural Product Likeliness | 1.684 |
| NR-PPAR-gamma | 0.886 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.01 |
| HIA | 0.052 |
| CACO-2 | -5.14 |
| MDCK | 0.00000977 |
| BBB | 0.094 |
| PPB | 0.960935 |
| VDSS | 0.434 |
| FU | 0.0420436 |
| CYP1A2-inh | 0.033 |
| CYP1A2-sub | 0.577 |
| CYP2c19-inh | 0.021 |
| CYP2c19-sub | 0.198 |
| CYP2c9-inh | 0.123 |
| CYP2c9-sub | 0.447 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.203 |
| CYP3a4-inh | 0.042 |
| CYP3a4-sub | 0.619 |
| CL | 4.197 |
| T12 | 0.768 |
| hERG | 0.078 |
| Ames | 0.064 |
| ROA | 0.284 |
| SkinSen | 0.898 |
| Carcinogencity | 0.269 |
| EI | 0.013 |
| Respiratory | 0.306 |
| NR-Aromatase | 0.193 |
| Antiviral | Yes |
| Prediction | 0.792325 |